Reckitt Benckiser Group plc (LON:RKT - Get Free Report) insider Fiona Dawson acquired 25 shares of the firm's stock in a transaction that occurred on Wednesday, October 23rd. The shares were bought at an average price of GBX 4,923 ($63.92) per share, with a total value of £1,230.75 ($1,597.96).
Reckitt Benckiser Group Price Performance
RKT traded down GBX 92 ($1.19) during trading on Thursday, reaching GBX 4,861 ($63.11). 2,134,034 shares of the company were exchanged, compared to its average volume of 3,350,471. The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 112.52. The company has a market cap of £33.60 billion, a price-to-earnings ratio of 2,261.29, a P/E/G ratio of 1.10 and a beta of 0.09. Reckitt Benckiser Group plc has a 12-month low of GBX 4,034 ($52.38) and a 12-month high of GBX 5,950 ($77.25). The company's 50-day moving average is GBX 4,532.62 and its two-hundred day moving average is GBX 4,420.32.
Analyst Upgrades and Downgrades
RKT has been the subject of several recent research reports. JPMorgan Chase & Co. lowered Reckitt Benckiser Group to a "neutral" rating in a report on Friday, August 30th. Jefferies Financial Group reiterated a "hold" rating and issued a GBX 4,400 ($57.13) target price on shares of Reckitt Benckiser Group in a research note on Monday, July 29th. Finally, Berenberg Bank dropped their price target on shares of Reckitt Benckiser Group from GBX 5,200 ($67.51) to GBX 5,177 ($67.22) and set a "hold" rating on the stock in a research note on Wednesday.
Read Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
